These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 334674)

  • 21. In-vitro evaluation of miokamycin: bactericidal activity against streptococci.
    Lacey RW; Lord VL; Howson GL
    J Antimicrob Chemother; 1984 Jan; 13(1):5-13. PubMed ID: 6607918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
    Suzaki K
    Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
    Rolston KV; LeBlanc B; Ho DH
    J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of midecamycin against Staphylococcus aureus.
    Peng CF; Chen TS
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Mar; 12(1):32-3. PubMed ID: 583273
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasmid copy number control: isolation and characterization of high-copy-number mutants of plasmid pE194.
    Weisblum B; Graham MY; Gryczan T; Dubnau D
    J Bacteriol; 1979 Jan; 137(1):635-43. PubMed ID: 104975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance to staphylococci. 3. Resistance to some macrolide antibiotics and inducible system.
    Kono M; Hashimoto H; Mitsuhashi S
    Jpn J Microbiol; 1966 Apr; 10(1):59-66. PubMed ID: 5297542
    [No Abstract]   [Full Text] [Related]  

  • 27. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy of four macrolide antibiotics with chloroquine against chloroquine-resistant Plasmodium falciparum in vitro.
    Gershon P; Howells RE
    Trans R Soc Trop Med Hyg; 1986; 80(5):753-7. PubMed ID: 3299891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic.
    Ose EE
    J Antibiot (Tokyo); 1987 Feb; 40(2):190-4. PubMed ID: 3570967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
    Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Resistance development in human Staphylococcus aureus due to the use of oxytetracycline and tylosin in industrialized swine production units].
    Hummel R; Witte W
    Arch Exp Veterinarmed; 1981; 35(3):419-32. PubMed ID: 7283644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrolide-lincosamide-resistant phenotypes and genotypes of Staphylococcus aureus isolated from bovine clinical mastitis.
    Wang Y; Wu CM; Lu LM; Ren GW; Cao XY; Shen JZ
    Vet Microbiol; 2008 Jul; 130(1-2):118-25. PubMed ID: 18272297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of tetracyclines, macrolide antibiotics, and sigmamycin on staphylococci in vitro].
    Betinová M
    Biologia (Bratisl); 1968; 23(9):675-82. PubMed ID: 4971503
    [No Abstract]   [Full Text] [Related]  

  • 34. Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments.
    Juntunen P; Olkkola S; Hänninen ML
    Vet Microbiol; 2011 Jun; 150(3-4):322-30. PubMed ID: 21397412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo antibacterial activity of 9,3"-Di-o-acetyl midecamycin (Mom), a new macrolide antibiotic.
    Kawaharajo K; Sekizawa Y; Inoue M
    J Antibiot (Tokyo); 1981 Apr; 34(4):436-42. PubMed ID: 6974163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the antimycoplasma activity of two commercially available tylosin premixes.
    Ose EE; Tonkinson LV
    Poult Sci; 1985 Feb; 64(2):287-93. PubMed ID: 3991415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic selection pressure resulting in multiple antibiotic resistance and localization of resistance determinants to conjugative plasmids in streptococci.
    Christie PJ; Dunny GM
    J Infect Dis; 1984 Jan; 149(1):74-82. PubMed ID: 6420477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 16-membered macrolide antibiotics: a review.
    Arsic B; Barber J; Čikoš A; Mladenovic M; Stankovic N; Novak P
    Int J Antimicrob Agents; 2018 Mar; 51(3):283-298. PubMed ID: 28668674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hygienic substantiation of using new antibiotic preparations, tylosin phosphate and vitagrin as food additives].
    Priputina LS; Ol'shevskaia OD; Zhil'skaia ZhIa
    Vopr Pitan; 1988; (4):63-7. PubMed ID: 3232342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological properties of new acyl derivatives of tylosin.
    Okamoto R; Tsuchiya M; Nomura H; Iguchi H; Kiyoshima K; Hori S; Inui T; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1309-15. PubMed ID: 7251472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.